Literature DB >> 10342413

Differential efficacy of intravenous lidocaine in alleviating ipsilateral versus contralateral neuropathic pain in the rat.

C J Sinnott1, J M Garfield, G R Strichartz.   

Abstract

In the this study we have investigated the threshold plasma concentration of lidocaine for reversal of mechanical 'allodynia' in a neuropathic pain model in the rat, defined the concentration-dependent limits of that reversal and compared the acute reversal during intravenous drug infusion with the persistent relief of allodynia assayed 48 h later. Actions of i.v. lidocaine on ipsilateral and contralateral legs were also assessed. Forty rats were sorted into five groups (n = 7-10) and underwent spinal root (L5-6) ligation to produce allodynia, as quantified by a lower force of von Frey hairs at the plantar hindpaw required to elicit paw withdrawal (PWT, paw withdrawal threshold). During surgery, intravenous catheters were placed for programmed lidocaine infusion and in some animals arterial catheters were also inserted for assaying lidocaine blood levels. PWTs were measured in ipsilateral and contralateral paws before and after ligation and during infusions which, beginning at 5 days after surgery, were conducted every other day to incrementing levels (1.1-9.7 microg/ml plasma). Ligation produced allodynia in ipsilateral paws (PWT = 1.22 +/- 0.42 g (+/-SEM)) and in contralateral paws (PWT = 4.99 +/- 0.61 g), both markedly lower than pre-operative control values for either paw (11.31 +/- 0.41 g). The ipsilateral allodynia was partially, but significantly and permanently reversed (to PWT = 6-8 g) after a lidocaine infusion to 2.1 microg/ml in two separate groups (n = 7, 8). Lower concentrations resulted in elevation of PWT during infusion but no sustained relief. The elevation of PWT during infusion at this threshold level among individual animals was positively correlated with the relief measured 48 h later, but higher lidocaine concentrations infused in subsequent dosings could exact no further sustained relief. The residual PWT level, after reversal by threshold lidocaine and greater, was constant for each individual rat tested over the next 14 days but varied substantially among individuals; some were restored to pre-operative PWTs and some were totally unresponsive to drug. Retrospective analysis revealed a significant and unanticipated correlation between the incidence of low pre-operative PWTs (< 10 g) and a lack of sustained reversal of post-operative allodynia by lidocaine. Contralateral allodynia, despite its acute reversal during infusion to 2.1 microg/ml and higher, was not persistently relieved after infusion of lidocaine to any concentration. Repeated infusions to subthreshold levels (<2 microg/ml) did not provide persisting relief of allodynia on either side, and infusions of saline were impotent. These findings show that experimental allodynia results from multiple factors, only some of which are sensitive to lidocaine treatment, and that prolonged reversal of allodynia is limited in extent and likely influenced by pre-existing factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342413     DOI: 10.1016/s0304-3959(98)00245-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  17 in total

1.  Systemic lidocaine and mexiletine for the treatment of a patient with total ulcerative colitis.

Authors:  Y Yokoyama; S Onishi
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  [New substances and applications for postoperative pain therapy].

Authors:  E M Pogatzki-Zahn; P K Zahn
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 3.  Intravenous lidocaine for neuropathic pain: diagnostic utility and therapeutic efficacy.

Authors:  Ian Carroll
Journal:  Curr Pain Headache Rep       Date:  2007-02

4.  Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats.

Authors:  Erin D Milligan; Carin Twining; Marucia Chacur; Joseph Biedenkapp; Kevin O'Connor; Stephen Poole; Kevin Tracey; David Martin; Steven F Maier; Linda R Watkins
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

5.  Behavioral characteristics of a mouse model of cancer pain.

Authors:  Bae Hwan Lee; Jinsil Seong; Un Jeng Kim; Ran Won; Jiyoung Kim
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

Review 6.  Behavioral models of pain states evoked by physical injury to the peripheral nerve.

Authors:  Linda S Sorkin; Tony L Yaksh
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

7.  The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain.

Authors:  Xiao-Wei Dong; Yuping Jia; Sherry X Lu; Xiaoping Zhou; Mary Cohen-Williams; Robert Hodgson; Huiqing Li; Tony Priestley
Journal:  Psychopharmacology (Berl)       Date:  2007-09-23       Impact factor: 4.530

8.  Contralateral paw sensitization following injection of endothelin-1: effects of local anesthetics differentiate peripheral and central processes.

Authors:  A Khodorova; G R Strichartz
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

9.  Mu-opioid receptor in the nucleus submedius: involvement in opioid-induced inhibition of mirror-image allodynia in a rat model of neuropathic pain.

Authors:  Jun-Yang Wang; Mei Zhao; Fen-Sheng Huang; Jing-Shi Tang; Yu-Kang Yuan
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

10.  Activation of spinal microglia in a murine model of peripheral inflammation-induced, long-lasting contralateral allodynia.

Authors:  Kristin L Schreiber; Alvin J Beitz; George L Wilcox
Journal:  Neurosci Lett       Date:  2008-05-17       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.